Market Place
Sourcing Support
MSN`s Generic Riociguat Receives Approval in the U.S.
01 Sep 2022 //
FDA
Bayer Announces Publication of Phase IV Adempas® (riociguat) Data
29 Mar 2021 //
BUSINESSWIRE
Bayer Announces Publication of Phase IV Adempas® (riociguat)
29 Mar 2021 //
BUSINESSWIRE
Switch to Riociguat Reduces Clinical Worsening in Patients With PAH Not Meeting
20 Oct 2020 //
FIRSTWORDPHARMA
Bayer Phase IV Study Met its Primary Endpoint in PAH Patients
07 Sep 2020 //
BIOSPACE
Adempas maker Bayer launches new hypertension support group
14 Jul 2018 //
FIERCE PHARMA
Adempas®(Riociguat Tablets): Adverio Pharma Gmbh V. Msn Laboratories Private
19 Jan 2018 //
PATENT LITIGATION
Adempas®(Riociguat Tablets): Adverio Pharma Gmbh V. Teva Pharmaceuticals Usa
19 Jan 2018 //
PATENT LITIGATION
Adempas® (Riociguat ): Adverio Pharma Gmbh V. Alembic Pharmaceuticals
09 Jan 2018 //
PATENT LITIGATION
FDA Confirms Paragraph IV Patent Challenge of Adempas (Riociguat) Tablets
08 Dec 2017 //
FDA
Another record year for Bayer – good progress with the acquisition of Monsanto
23 Feb 2017 //
PRESS RELEASE
Bayer`s hefty 2016 growth underlines danger of neglecting R&D for Monsanto
22 Feb 2017 //
FIERCE PHARMA
Bayer`s struggling Stivarga moves closer to liver-cancer lifeline
04 Jan 2017 //
FIERCE PHARMA
Bayer’s Adempas (Riociguat) Receives Supplemental Approval in US
04 Oct 2016 //
FDA
U.S. Patent Term Extension for Bayer’s Adempas
21 Mar 2016 //
TWOFOUR INSIGHT
Actelion says selexipag to enter U.S. market in January
22 Dec 2015 //
REUTERS
With FDA nod, Actelion adds blockbuster hopeful Uptravi to PAH portfolio
22 Dec 2015 //
FIERCE PHARMA
GSK earns expanded approval for Volibris in Europe
26 Nov 2015 //
PM LIVE
Anvisa approves novel medicines for asthma, hypertension and brain tumor
05 Oct 2015 //
ANVISA
Gilead and GSK pulmonary hypertension drugs work in tandem
28 Aug 2015 //
PM LIVE
Strong start to the year for Bayer
01 May 2015 //
WORLD PHARMA NEWS
Bayer`s Eylea Cleared for Wider Use in Europe
27 Feb 2015 //
PMLIVE
Bayer Counts On Consumer Health, Pharma Growth to Power 2015
26 Feb 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.